Protein kinases are enzymes that catalyze the transfer of phosphate groups from ATP molecules to various substrates. The process is known as phosphorylation. Kinases regulate many cellar functions, so the overaction of protein kinases in cancer cells may cause fast tumor growth. Thus, kinase-inhibiting molecules might act as antitumor agents and can be used in cancer treatments.

Kinase Inhibitor Library Max designed by our specialists is the maximum library and contains 1325 carefully selected small kinase inhibitors. It covers the wide scope of kinase targets and includes approved drugs, highly selective and broad-spectrum inhibitors, and the most recent discoveries.

Related terms: receptor tyrosine kinase, RTK, nRTK, CAMK, calcium/calmodulin-dependent protein kinase, mitogen-activated protein kinase, MAP, cyclin-dependent kinase, CDK, glycogen synthase kinase, GSK